)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Haemonetics
Haemonetics (HAE) investor relations material
Haemonetics 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary13 Jan, 2026
Strategic overview and portfolio evolution
Leadership in plasma apheresis, a $1B market with mid-single digit growth and robust cash flow.
Diversified into MedSurg markets and prioritized high-growth areas such as plasma, blood management, and interventional technologies, while rationalizing legacy segments.
Three core platforms—plasma, blood management, and interventional technologies—now generate most revenue, with 75% of revenue U.S.-based, providing a buffer against geopolitical and macroeconomic risks.
Portfolio transitions and optimization have created a high-margin, recurring revenue base with improved operating leverage.
Emphasis on diversification across business segments, customers, geographies, and business models, alongside sustainability in economic, societal, and environmental areas.
Financial performance and long-range plan (LRP)
Achieved 8% total revenue CAGR and 13% organic revenue CAGR (excluding major customer transition and divestitures), with recurring revenue comprising up to 94% of total revenue.
Operating income margin improved by 770 basis points, reaching 26.3% in the latest quarter and projected at 26-27% in FY'26.
Adjusted EPS compounding at 17%, rising from $2.58 in FY'22 to a projected $4.90 in FY'26, supported by pricing, productivity, and revenue mix.
Free cash flow conversion at 92%, with FY'26 guidance for free cash flow between $170M and $210M.
ROIC increased from ~6.7% in FY'22 to ~11% in Q2 YTD FY'26, reflecting a focus on value creation and efficient capital deployment.
Core product platforms and market leadership
NexSys PCS leads plasma collection with over 50% market share and strong customer engagement, supported by integrated solutions that reduce cost per liter and enhance donor experience.
NexLynk DMS holds 80% U.S. market share, enhancing productivity and operational visibility.
TEG 6s is the standard in viscoelastic testing, with 45% global share, double-digit growth, and a strong pipeline for international expansion.
Vascade family dominates vascular closure in electrophysiology, targeting a $600M serviceable market, with portfolio expansion through the Vivasure acquisition.
Recent Vivasure acquisition expands into large bore closure, a $300M market, with PerQseal Elite under FDA review and category leadership from 5F to 22F.
Key drivers for high growth portfolio expansion
M&A strategy for future value creation
Operational levers for margin expansion
IVT turnaround plan and Vivasure integration
Future operating margin expansion drivers
Capital allocation priorities post-March debt
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Haemonetics earnings date
Q3 20265 Feb, 2026
Haemonetics
Next Haemonetics earnings date
Q3 20265 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Haemonetics Corporation provides hematology products and solutions. The company offers blood and plasma collection systems to collect, process, and return blood to the patient; surgical blood salvage systems to safely and effectively collect and re-infuse patients' own red blood cells that would otherwise be discarded during surgery; and transfusion administrations systems, including software, disposables and data management services to help hospitals operate their transfusion processes, and effectively manage the complications associated with patient blood management. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage